Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria–type cells in bone marrow failure syndrome
Authors:
- 1 December 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (12) , 3897-3902
Abstract
A minor population of blood cells deficient of glycosylphosphatidylinositol (GPI)–anchored membrane proteins is often detected in patients with aplastic anemia (AA), though the clinical significance of such paroxysmal nocturnal hemoglobinuria (PNH)–type cells remains unclear. To clarify this issue, we studied 164 patients with myelodysplastic syndrome (MDS) for the presence of CD55−CD59− granulocytes and red blood cells using sensitive flow cytometry. Among the different subgroups of MDS, a significant increase (ie, at least 0.003%) of PNH-type cells was detected in 21 of 119 patients with refractory anemia (RA); this frequency (17.6%) of RA patients with increased PNH-type cells (PNH+ patients) was much lower than what we previously reported (52.0%) for AA patients. PNH+ RA patients had distinct clinical features compared with RA patients without increased PNH-type cells (PNH− patients), such as less pronounced morphologic abnormality of blood cells, more severe thrombocytopenia, lower rates of karyotypic abnormality (4.8% vs 32.8%) and of progression to acute leukemia (0% vs 6.2%), higher probability of response to cyclosporine therapy (77.8% vs 0%), and higher incidence of HLA-DR15 (90.5% vs 18.5%). These data indicate that the presence of a minor population of PNH-type cells suggests a benign type of bone marrow failure, probably caused by an immunologic mechanism. To choose an appropriate therapy, peripheral blood should be tested using sensitive flow cytometry for the presence of PNH-type cells in all patients with bone marrow failure before treatment.Keywords
This publication has 31 references indexed in Scilit:
- Flow cytometric analysis of an expansion paroxysmal nocturnal hemoglobinuria (PNH) clone in a patient with bone marrow failureAmerican Journal of Hematology, 2001
- Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotypeBlood, 2001
- Good response to cyclosporine therapy in patients with myelodysplastic syndrromes having the HLA-DRB1*1501 alleleLeukemia, 2000
- HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtypePathology and Oncology Research, 1997
- ROLE OF PHOSPHATIDYLINOSITOL-LINKED PROTEINS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATHOGENESISAnnual Review of Medicine, 1996
- Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapyBritish Journal of Haematology, 1995
- Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individualsTissue Antigens, 1994
- Myelodysplasia and Leukemia after Treatment of Aplastic Anemia with G-CSFNew England Journal of Medicine, 1992
- Refractory myelodysplastic anaemias with hypocellular bone marrow.Journal of Clinical Pathology, 1988
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982